Description
This product utilizes cytokine-Induced T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO22). We employs the HBV (CMV-mCherry-IL-10-XbaI) vector components and the SynExpress system of the introns Substitution/Balancing feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO22
Species Reactivity
Human
Cell Source
Cytokine-Induced T cells
Sensor Gene
mCherry
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
XbaI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.